![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NEUROMED NAMED TO 'FIERCE 15' LIST OF TOP EMERGING BIOTECH COMPANIES IN 2006
NEUROMED NAMED TO 'FIERCE 15' LIST OF TOP EMERGING BIOTECH COMPANIES IN 2006
April 12, 2006
Neuromed Pharmaceuticals, a biopharmaceutical company developing next-generation chronic pain drugs, announced today that it has been named to FierceBiotech's annual Fierce 15 list of top biotech companies to watch. This distinction, which was announced during the annual BIO meeting in Chicago, recognizes Neuromed as one of the top emerging biotech companies in 2006.
CNW Group (http://www.newswire.ca/en/releases/archive/April2006/12/c4096.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct